BioSpace News Archive

Powerhouse tech companies Salesforce, a customer relationship management solution, and G2, the world’s leading business software and review platform, are joining forces as sponsors of the American Cancer Society’s 2020 Discovery Ball: Be Bold and Rise Up.

Mercaptor Discoveries (Mercaptor), a platform company with preclinical programs in epilepsy and TBI, today announced that it is pivoting its proprietary neurotherapeutic development plan toward COVID-19.

Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services announces virtual educational opportunities to support the research community, including topics to help sites, sponsors, and CROs through the coronavirus (COVID-19)

Gold Standard Diagnostics Inc. today announced the EUA submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay for the direct qualitative pathogen detection of the novel coronavirus (SARS-CoV-2). The assay is available now for purchase in the U.S. Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is critical. PCR is the method

ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients receive the care they need from home. This press release features multimedia. View the full release here: https://www.businesswire.com/ne

NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, announced today the filing of a provisional patent application around the usage of the NELL1 signaling protein in the treatment of respiratory viral infections including COVID-19. The patent

PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCK™ (ripretinib)

Data demonstrate that late dosing results in failure to maintain testosterone suppression to recommended levels for disease management

New research from CSHL scientists suggests that cigarette smoke spurs the lungs to make more ACE2, the protein that the coronavirus responsible for COVID-19 grabs and uses to enter human cells.

Sophiris Bio Inc., announced that its board of directors has formally approved an immediate shutdown of the operations of the Company.